NextCure, Inc.
NXTC
$12.32
$0.363.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.44M | -8.62M | -26.81M | -10.98M | -11.60M |
| Total Depreciation and Amortization | 365.00K | 533.00K | 633.00K | 654.00K | 674.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 537.00K | 702.00K | 585.00K | 1.27M | 1.38M |
| Change in Net Operating Assets | 896.00K | 1.12M | 2.88M | -3.94M | 2.59M |
| Cash from Operations | -7.64M | -6.27M | -22.71M | -12.99M | -6.97M |
| Capital Expenditure | -- | -- | -- | -- | 34.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.00M | 8.70M | 3.76M | 7.09M | 6.92M |
| Cash from Investing | 6.00M | 8.70M | 3.76M | 7.09M | 6.96M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 21.52M | 0.00 | 2.02M | -- | 37.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.22M | -- | -- | -- | -- |
| Cash from Financing | 20.29M | 0.00 | 2.02M | -- | 37.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.66M | 2.43M | -16.94M | -5.90M | 26.00K |